Wells J S, Trejo W H, Principe P A, Bush K, Georgopapadakou N, Bonner D P, Sykes R B
J Antibiot (Tokyo). 1982 Feb;35(2):184-8. doi: 10.7164/antibiotics.35.184.
Strains of Chromobacterium violaceum, isolated from various environments, were found to produce a novel monocyclic beta-lactam antibiotic. The antibiotic, SQ 26,180 was weakly active against Gram-positive and Gram-negative bacteria with the exception of mutants hypersensitive to beta-lactam antibiotics. The compound was highly stable to beta-lactamases and acted as an inhibitor of the P99 enzyme from Enterobacter cloacae. SQ 26,180 showed affinity for penicillin-binding proteins 1a, 4 and 5/6 of Escherichia coli and inhibited R61 DD-carboxypeptidases.
从各种环境中分离出的紫色色杆菌菌株被发现能产生一种新型单环β-内酰胺抗生素。这种抗生素SQ 26,180对革兰氏阳性菌和革兰氏阴性菌活性较弱,但对β-内酰胺抗生素超敏感的突变体除外。该化合物对β-内酰胺酶高度稳定,并可作为阴沟肠杆菌P99酶的抑制剂。SQ 26,180对大肠杆菌的青霉素结合蛋白1a、4和5/6具有亲和力,并能抑制R61 D-羧肽酶。